Citations

Showing 10 of 108152 citations.

Current State of Evidence on Kidney Transplantation: How Fragile Are the Results?
Budhiraja, Pooja , Kaplan, Bruce , Kalot, Mohamad A. , Alayli, Abdallah El , Dimassi, Ahmad , Chakkera, Harini A. , Heilman, Raymond L. , Edwards, Audrene, Heilman, Raymond, Kalot, Mohamad A , Chakkera, Harini A , Budhiraja, Pooja , Mustafa, Reem A

Mayo Clinic

Transplantation | May 10, 2021 | Volume: 106 | Issue: 2 | Pages: 248-256

10.1097/tp.0000000000003805 | PMID 33966022 Get It

Background. The study aims is to use the fragility index (FI) to examine the strength of evidence of randomized controlled trials (RCTs) published in the last decade on kidney transplantation. Methods. We searched MEDLINE for studies on kidney transplantation. We included the RCTs that compared 2 groups with 1:1 randomization and reported significant P values (<0.05) for a dichotomous outcome and were published in the top 10 transplant journals. We calculated the FI; a calculation used to determine the minimum number of subjects needed to change from a nonevent to an event to make the study results nonsignificant (P ≥ 0.05). Results. Fifty-seven RCTs met our inclusion criteria. The median sample size was 100 participants in each arm, the median number of events was 16 (interquartile range, 8–30) in the intervention group. Among the included trials, 79% were industry-funded, 93% involved medications, and the majority were open label. The median FI was 3 (interquartile range, 1–11). In 43% of the trials, the number of patients reported lost to follow-up was higher than or equal to the FI. Only 4% of the RCTs imputed a value for the missing dichotomous outcome. Furthermore, the median number of subjects who discontinued the trial because of adverse effects was 21, which was greater than the FI in 60% of the RCTs. Conclusions. The arbitrary classification of results into “significant” and “nonsignificant” based on P value <0.05 should perhaps be interpreted with the help of other statistical parameters and FI is one of them.
Spatial Thermodynamics of very High Power-Short Duration Catheter Ablation for Pulmonary Vein Isolation in an in-vivo model
Suzuki, Atsushi , Lehmann, H. Immo , Wang, Songyun , Parker, Kay, Monahan, Kristi H. , Packer, Douglas L. , Suzuki, Atsushi , Parker, Kay, Rettmann, Maryam E.

Mayo Clinic

No container title available | May 10, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.22541/au.162065770.06236007/v1 Get It

Introduction: The spatial thermodynamics of very high power-short duration (vHPSD) radiofrequency (RF) application during pulmonary vein isolation (PVI) in in-vivo model has not been well characterized. This study was conducted to investigate the distance-temperature relationship during vHPSD-RF ablation. Methods: PVI was performed using the vHPSD catheter with the settings of 90W, RF time of 4 sec and 15mL/min irrigation in a canine model. Catheter contact force (CF) of 10-20g was defined as ‘normal’ and CF >20g as ‘firm’ CF. Tissue temperature was monitored using thermocouples implanted at the surface of the left atrial-pulmonary vein junction, left phrenic nerve, and the luminal esophagus. PVI using a standard contact-force sensing catheter (SCF) (settings of 35W, 30sec and 30mL/min irrigation) was performed for comparison. Results: A total of 334 TC profiles in 4 animals was investigated. Time to maximum tissue temperature (MTT) (6.0sec [vHPSD/normal CF] vs. 30.5 sec [SCF/normal CF], p<0.001; 8.0sec [vHPSD/firm CF] vs. 24.0sec [SCF/firm CF], p=0.022) was shorter with vHPSD than in SCF groups. MTT within 10mm from catheter-tip was lower in vHPSD ablation with normal CF than using SCF ablation (median 41.9°C [interquartile-range; 40.2-46.1] vs. 49.5°C [45.9-56.2], p=0.013). The distance margin to keep the MTT below 39ºC, 42ºC, and 50ºC were 4.9mm, 4.2mm, and 3.4mm, respectively in the vHPDS group. This margin was larger (8.0mm, 6.6mm, and 4.6mm) in the SCF group. Conclusion: Our study underscores that vHPSD creates greater resistive heating than conventional catheter ablation.
Cerebral Microbleeds
Graff‐Radford, Jonathan , Lesnick, Timothy G. , Rabinstein, Alejandro A. , Gunter, Jeffrey L. , Przybelski, Scott A. , Noseworthy, Peter A. , Preboske, Gregory M., Mielke, Michelle M. , Lowe, Val J. , Knopman, David S. , Petersen, Ronald C. , Kremers, Walter K. , Jack, Clifford R. , Vemuri, Prashanthi , Kantarci, Kejal , Knopman, David S. , Lesnick, Timothy, Jack, Clifford R , Noseworthy, Peter A , Mielke, Michelle M , Vemuri, Prashanthi , Kantarci, Kejal , Gunter, Jeffrey L , Rabinstein, Alejandro A , Kremers, Walter K

Mayo Clinic

Stroke | May 10, 2021 | Volume: 52 | Issue: 7 | Pages: 2347-2355

10.1161/strokeaha.120.031515 | PMID 33966498 Get It

Background and Purpose: Cerebral microbleeds (CMBs) are represented by small areas of hemosiderin deposition, detected on brain magnetic resonance imaging (MRI), and found in ≈23% of the cognitively normal population over age of 60 years. CMBs predict risk of hemorrhagic and ischemic stroke. They correlate with increased cardiovascular mortality. In this article, we sought to determine in a population-based study whether antithrombotic medications correlate with CMBs and, if present, whether the association was direct or mediated by another variable. Methods: The study consisted of 1253 participants from the population-based Mayo Clinic Study of Aging who underwent T2* gradient-recalled echo magnetic resonance imaging. We tested the relationship between antithrombotic medications and CMB presence and location, using multivariable logistic-regression models. Ordinal logistic models tested the relationship between antithrombotics and CMB frequency. Using structural equation models, we assessed the effect of antithrombotic medications on presence/absence of CMBs and count of CMBs in the CMB-positive group, after considering the effects of age, sex, vascular risk factors, amyloid load by positron emission tomography, and apoE. Results: Two hundred ninety-five participants (26.3%) had CMBs. Among 678 participants taking only antiplatelet medications, 185 (27.3%) had CMBs. Among 95 participants taking only an anticoagulant, 43 (45.3%) had CMBs. Among 44 participants taking an anticoagulant and antiplatelet therapy, 21 (48.8%) had CMBs. Anticoagulants correlated with the presence and frequency of CMBs, whereas antiplatelet agents were not. Structural equation models showed that predictors for presence/absence of CMBs included older age at magnetic resonance imaging, male sex, and anticoagulant use. Predictors of CMB count in the CMB-positive group were male sex and amyloid load. Conclusions: Anticoagulant use correlated with presence of CMBs in the general population. Amyloid positron emission tomography correlated with the count of CMBs in the CMB-positive group.
Bilateral Lung transplantation for Pulmonary Artery Aneurysm with Severe Pulmonary Hypertension: An Evolution or A Revolution?
Jacob, Samuel , Pham, Anthony , Sareyyüpoğlu, Başar , Pham, Anthony, Pham, Si M.

Mayo Clinic

No container title available | May 10, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.22541/au.162065000.05055063/v1 Get It

The surgical treatment of pulmonary hypertension (PH), with or without pulmonary artery aneurysm, has evolved during the last 40 years from heart-lung transplants to bilateral lung transplants as the treatment of choice for PH patients with preserved right and left ventricular function and without complex cardiac abnomalies.
Human meniscus allograft augmentation by allogeneic mesenchymal stromal/stem cell injections
Struijk, Caroline , Genechten, Wouter Van , Verdonk, Peter , Krych, Aaron J. , Dietz, Allan B. , Wijnen, André J. van , Saris, Daniël B.F. , Van Genechten, Wouter , van Wijnen, Andre J , Krych, Aaron J , Dietz, Allan B

Mayo Clinic

Journal of Orthopaedic Research | May 10, 2021 | Volume: 40 | Issue: 3 | Pages: 712-726

10.1002/jor.25074 | PMID 33969529 Get It

AbstractMeniscus allograft transplantations (MATs) represent established surgical procedures with proven outcomes. Yet, storage as frozen specimens and limited cellular repopulation may impair graft viability. This proof‐of‐concept study tests the feasibility of injecting allogeneic mesenchymal stromal/stem cells (MSCs) in meniscus allograft tissue. We investigated the injectable cell quantity, survival rate, migration, and proliferation ability of MSCs up to 28 days of incubation. In this controlled laboratory study, seven fresh‐frozen human allografts were injected with human allogeneic MSCs. Cells were labeled and histological characteristics were microscopically imaged up to 28 days. Mock‐injected menisci were included as negative controls in each experiment. Toluidine blue staining demonstrated that a 100‐µl volume can be injected while retracting and rotating the inserted needle. Immediately after injection, labeled MSCs were distributed throughout the injection channel and eventually migrated into the surrounding tissues. Histological assessment revealed that MSCs cluster in disc‐like shapes, parallel to the intrinsic lamination of the meniscus and around the vascular network. Quantification showed that more than 60% of cells were present in horizontally injected grafts and more than 30% were observed in vertically injected samples. On Day 14, cells adopted a spindle‐shaped morphology and exhibited proliferative and migratory behaviors. On Day 28, live/dead ratio assessment revealed an approximately 80% cell survival. The study demonstrated the feasibility of injecting doses of MSCs (>0.1 million) in meniscus allograft tissue with active cell proliferation, migration, and robust cell survival.
Managing the first 120 min of cardiogenic shock: from resuscitation to diagnosis
Burstein, Barry , Jentzer, Jacob C. , Tabi, Meir

Mayo Clinic

Current Opinion in Critical Care | May 10, 2021 | Volume: 27 | Issue: 4 | Pages: 416-425

10.1097/mcc.0000000000000839 | PMID 33967208 Get It

Purpose of review Cardiogenic shock continues to carry a high mortality, and recent randomized trials have not identified novel therapies that improve survival. Early optimization of patients with confirmed or suspected cardiogenic shock is crucial, as patients can quickly transition from a hemodynamic shock state to a treatment-resistant hemometabolic shock state, where accumulated metabolic derangements trigger a self-perpetuating cycle of worsening shock. Recent findings We describe a structured ABCDE approach involving stabilization of the airway, breathing and circulation, followed by damage control and etiologic assessment. Respiratory failure is common and many cardiogenic shock patients require invasive mechanical ventilation. Norepinephrine is titrated to restore mean arterial pressure and dobutamine is titrated to restore cardiac output and organ perfusion. Echocardiography is essential to identify potential causes and characterize the phenotype of cardiogenic shock. Coronary angiography is usually indicated, particularly when acute myocardial ischemia is suspected, followed by culprit-vessel revascularization if indicated. An invasive hemodynamic assessment can clarify whether temporary mechanical circulatory support is necessary. Summary Early stabilization of hemodynamics and end-organ function is necessary to achieve best outcomes in cardiogenic shock. Using a structured approach tailored to initial cardiogenic shock resuscitation may help to demonstrate benefit from novel therapies in the future.
Intraoperative Hypoxia Independently Associated With the Development of Acute Kidney Injury Following Bilateral Orthotopic Lung Transplantation
Knight, Joshua, Hill, Adam, Melnyk, Vladyslav, Doney, Luke, D’Cunha, Jonathan, Kenkre, Tanya, Subramaniam, Kathirvel, Howard-Quijano, Kimberly, Knight, Joshua, Hill, Adam, Melnyk, Vladyslav, Doney, Luke, D’Cunha, Jonathan, Kenkre, Tanya, Subramaniam, Kathirvel, Howard-Quijano, Kimberly

Mayo Clinic

Transplantation | May 10, 2021 | Volume: 106 | Issue: 4 | Pages: 879-886

10.1097/tp.0000000000003814 | PMID 33966025 Get It

Background. Acute kidney injury (AKI) is a common postoperative complication in bilateral orthotopic lung transplant (BOLTx) recipients, but the contribution of intraoperative variables is not well defined. The authors hypothesized that intraoperative hypotension as well as hypoxia and vasopressor use would be associated with the development of postoperative AKI after BOLTx in patients without pre-existing renal dysfunction. Methods. The authors performed a retrospective analysis of patients undergoing BOLTx at a single center between 2013 and 2017. Intraoperative variables of hemodynamics included duration of mean arterial pressure <55, <60, and <65 mm Hg; duration of oxygen saturation <90%; and vasoactive-inotropic score (VIS). Associations between the occurrence of AKI and intraoperative hypotension, hypoxemia, and VIS were evaluated while controlling for significant confounding variables. Results. AKI occurred in 177 (72%) of 245 patients in postoperative days 1–7. Notable significant differences in univariate analyses included cumulative mechanical support time, maximum VIS, peripheral oxygen saturation <90% for >15 min, total minutes oxygen saturation <90%, and surgery duration in minutes. There was no significant difference in intraoperative hypotension measured as a duration >15 min for mean arterial pressure <55, <60, or <65 mm Hg. Multivariate logistic regression revealed preoperative creatinine (Odds ratio [OR], 7.77; confidence interval [CI], 1.96-30.83; P = 0.004), surgery duration (OR, 1.004; CI, 1.002-1.007; P = 0.002), and oxygen saturation (OR, 2.06; CI, 1.01-4.24; P = 0.049) <90% for >15 min to be independently associated with AKI. Conclusions. This study revealed that >15 min of intraoperative hypoxia was independently associated with postoperative AKI after BOLTx.
Categorizing metadata to help mobilize computable biomedical knowledge
Alper, Brian S. , Flynn, Allen , Conte, Marisa , Eldredge, Christina , Gold, Sigfried , Greenes, Robert A. , Haug, Peter J. , Jacoby, Kim, Koru, Güneş , McClay, James C. , Sainvil, Marc L. , Sottara, Davide , Tuttle, Mark S. , Visweswaran, Shyam , Yurk, Robin , Conte, Marisa L , Gold, Sigfried , Koru, Gunes , McClay, James , Sainvil, Marc L , Tuttle, Mark , Visweswaran, Shyam , Yurk, Robin Ann , Alper, Brian S , Bray, Bruce E.

Mayo Clinic

Learning Health Systems | May 10, 2021 | Volume: 6 | Issue: 1 | Pages: No page available

10.1002/lrh2.10271 | PMID 35036552 Get It

AbstractIntroductionComputable biomedical knowledge artifacts (CBKs) are digital objects conveying biomedical knowledge in machine‐interpretable structures. As more CBKs are produced and their complexity increases, the value obtained from sharing CBKs grows. Mobilizing CBKs and sharing them widely can only be achieved if the CBKs are findable, accessible, interoperable, reusable, and trustable (FAIR+T). To help mobilize CBKs, we describe our efforts to outline metadata categories to make CBKs FAIR+T.MethodsWe examined the literature regarding metadata with the potential to make digital artifacts FAIR+T. We also examined metadata available online today for actual CBKs of 12 different types. With iterative refinement, we came to a consensus on key categories of metadata that, when taken together, can make CBKs FAIR+T. We use subject‐predicate‐object triples to more clearly differentiate metadata categories.ResultsWe defined 13 categories of CBK metadata most relevant to making CBKs FAIR+T. Eleven of these categories (type, domain, purpose, identification, location, CBK‐to‐CBK relationships, technical, authorization and rights management, provenance, evidential basis, and evidence from use metadata) are evident today where CBKs are stored online. Two additional categories (preservation and integrity metadata) were not evident in our examples. We provide a research agenda to guide further study and development of these and other metadata categories.ConclusionA wide variety of metadata elements in various categories is needed to make CBKs FAIR+T. More work is needed to develop a common framework for CBK metadata that can make CBKs FAIR+T for all stakeholders.
Old age genetically confirmed frontotemporal lobar degeneration with TDP‐43 has limbic predominant TDP‐43 deposition
Buciuc, Marina , Whitwell, Jennifer L. , Rademakers, Rosa , Josephs, Keith A. , Baker, Matthew C, Buciuc, Marina , Whitwell, Jennifer L. , Baker, Matthew , Dickson, Dennis W.

Mayo Clinic

Neuropathology and Applied Neurobiology | May 9, 2021 | Volume: 47 | Issue: 7 | Pages: 1050-1059

10.1111/nan.12727 | PMID 33969528 Get It

Abstract Aims To assess the burden of transactive response DNA‐binding protein of 43 kDa (TDP‐43) inclusions in a unique cohort of old‐age patients with genetic frontotemporal lobar degeneration (gFTLD‐TDP) and compare these patients with sporadic old‐age individuals with TDP‐43, either in the presence of Alzheimer's disease (AD‐TDP) or in isolation (pure‐TDP). Methods The brain bank at Mayo Clinic‐Jacksonville was searched for cases ≥75 years old at death with TDP‐43 extending into middle frontal cortex. Cases were split into the following groups: (1) gFTLD‐TDP ( n = 15) with progranulin ( GRN )/ C9ORF72 mutations; (2) AD‐TDP ( n = 10)—cases with median Braak neurofibrillary tangle (NFT) stage VI, Thal phase V; (3) pure‐TDP ( n = 10)—cases with median Braak NFT stage I, Thal phase I. Clinical data were abstracted; TDP‐43 burden was calculated using digital pathology. Results Amnestic Alzheimer's dementia was the clinical diagnosis in ≥50% patients in each group. The distribution of TDP‐43 burden in gFTLD‐TDP and AD‐TDP, but not pure‐TDP, was limbic‐predominant targeting CA1 and subiculum. Patients with gFTLD‐TDP had higher burden in entorhinal cortex compared to AD‐TDP. TDP‐43 burden in middle frontal cortex did not differ between the three groups. Conclusions In old age it is challenging to clinically and pathologically differentiate gFTLD‐TDP from AD‐TDP and pure‐TDP‐43 based on burden. Like AD‐TDP, old age gFTLD‐TDP have a limbic predominant TDP‐43 distribution. The finding that amnestic Alzheimer's dementia was the most common clinical diagnosis regardless of group suggests that TDP‐43 directly and indirectly targets limbic regions.
Enhanced Recovery: A Decade of Experience and Future Prospects at the Mayo Clinic
Lovely, Jenna K. , Larson, David W.

Mayo Clinic

Healthcare | May 9, 2021 | Volume: 9 | Issue: 5 | Pages: 549

10.3390/healthcare9050549 | PMID 34066696 Get It

This work aims to describe the implementation and subsequent learnings from the first decade after the full implementation of enhanced recovery pathway for colorectal surgery at a single institution. This paper will describe the diffusion efforts and plans through the Define, Measure, Analyze, Improve, Control (DMAIC) process of ongoing quality improvement and through research efforts. The information applies to all readers that provide surgical care within their organization as the fundamental principles of enhanced recovery for surgery are applicable regardless of the setting.